Real-World Evidence for Market Access and Regulatory Strategy
Book a session
| Date | Product | Location | Price | |
|---|---|---|---|---|
| No sessions are planned at this time, however if you are interested in taking this course click here | ||||
| If you would like to have this course as an in-house session click here | ||||
About this course
Reasons to attend
Unlock the power of real-world evidence to drive access and approval. This focused one-day course gives you the tools to generate and apply RWE that meets the needs of both regulators and payers. Through expert-led sessions and real-world case studies, you'll discover how to turn real-world data into regulatory-grade insights that strengthen value claims, accelerate reimbursement, and support strategic decision-making across your organisation.What's included?
- Documents and materials related to this course are included
- Globally recognised certificates awarded after test completion
Course schedule
We provide this course in Classroom format.Classroom: 1-Day face-to-face: 09:00 - 17:00 |
Course Description
Real-world evidence (RWE) is no longer a "nice to have." It is now a core requirement for regulatory and market access success. As regulators and payers increasingly turn to data from everyday clinical practice to assess the safety, effectiveness, and value of new therapies, industry professionals must be equipped to navigate this evolving landscape.This in-depth one-day course gives HEOR professionals, medical affairs teams, regulatory specialists, and market access managers a practical framework for generating and applying real-world evidence that supports approvals, reimbursement, and strategic positioning. You will explore the full range of real-world data (RWD) sources, including electronic health records, claims databases, registries, patient-reported outcomes, and digital health technologies, and understand how to assess their suitability for different objectives.
The course also covers key methodological approaches, from observational study design to data quality assessment and bias mitigation. You will gain insights into how regulatory agencies such as the FDA and EMA evaluate RWE in the context of submissions and approvals, as well as how HTA bodies and payers use RWE to inform pricing and access decisions.
Through real-world case studies and interactive discussions, you will learn how to design, interpret, and present RWE that meets the expectations of both regulators and payers. Whether you are developing a value dossier, preparing a regulatory submission, or building an evidence package to support pricing negotiations, this course will equip you with the knowledge and confidence to deliver credible and impactful RWE.
Programme highlight
- Introduction to real-world data (RWD) sources commonly used in regulatory and market access settings
- Overview of study designs and practical considerations when generating real-world evidence (RWE)
- Discussion of how regulatory bodies and HTA agencies are incorporating RWE into decision-making
- Case examples illustrating the use of RWE in submissions and value communications
- Group discussions on common challenges and strategies for cross-functional alignment
- Interactive sessions to reflect on how RWE can be applied within participants’ own roles
Learning objectives
By the end of this course, participants will:
- Describe the types of real-world data used in healthcare decision-making
- Recognise basic methodological approaches for generating RWE
- Understand how regulators and payers are currently using RWE to inform their assessments
- Reflect on how RWE might support regulatory submissions or market access strategies in their own context
- Identify key considerations and potential limitations when working with RWD
Who should attend
Who should attend? This course is designed for professionals involved in the generation, interpretation, and application of real-world evidence to support regulatory and market access strategies, including:
- Health Economics and Outcomes Research (HEOR) professionals
- Medical Affairs teams
- Regulatory Affairs specialists
- Market Access and Reimbursement managers
- Clinical Development professionals working on post-approval or observational research
- Anyone responsible for evidence generation, value demonstration, or HTA submissions
Competencies
This course covers competencies that are part of the ECCRT Competency Framework
- Scientific Concepts & Research Design ()
- Ethical & Participants Safety Considerations ()
- Investigational Product Development and Regulation ()
- Clinical Studies Operations (GCPs or ISO 14155) ()
- Study and Site Management ()
- Data Management and Informatics ()
- Leadership and Professionalism ()
- Communication ()
- Teamwork ()
- Business acumen ()
Trainers
No testimonial yet